2Eseribano Subias P,Barbera Mir JA,Suberviola V.CmTent diagnostic and prognostic assessment of pulmonary hypertension [J].Rev Esp Cardiol,2010,63(5):583-596.
3Buler J,Chomsky DB,Wilson JR,et at. pulmonary hypertension and exercise intolerance in patients with hearl failure.J Am coil Cardiol, 1999,34:1802-1806.
4Abramsan SV,Burke iF,Kelly JJ Jr,et al. pulmonary hypertension predicts mortality and morbidity in patients with dilated eardiomyopathy[j].Ann Inter Me(l, 1992,116(11):888-895.
5Richs A,Smajiv J,Aimee J,et al. Risk Assessment in pulmonary hypertension Associated with hear~ failure and preserved ejection fraction.J Heart Lung Transplant, 2012,31:467-477.
6Deado JF.The pulmonary circulation in heart failure[J]. Rev EspCardiol,2010,63 (3):334-345.
7程显生.血管病学[M].北京:北京医科大学中国协和医科大学联合出版社.993:196-205.
8Kee k,Naughton MT.Heart failure and the lung[J].Circ J,2010,74 (12):2507-2516.
9Carolyn S,Veronique L,Richard J,et al. Pulmonary hypertension in heart failure with preserved ejection fraction:A Community-Based Study.J Am Coil Cardiol,2009,53:1119-1126.
10Gugin M,Khan 1-LPulmonary hypertension in heart failure[J]3 Cardiac Fail 2010,16(6):461-474.
3Tuder RM, Stacher E, Robinson J, et al. Pathology of pulmonary hypertension[J]. Clin Chest Med, 2013, 34(4): 639-650.
4Villegas LR, Kluck D. Field C, et al. Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome[J]. Antioxid Redox Signal, 2013, 18(14): 1753-1764.
5Gao C, Xu W, Xiao W, et al. Simvastatin decreases stent-induced in-stent restenosis rate via downregulating the expression of PCNA and upregulating that of p27kipl[J]. J Interv Cardiol, 2013, 26(4): 384-39I.
6Zhang Z, Zhang M, Li Y, et al. Simvastatin inhibits the additive activation of ERKI/2 and proliferation of rat vascular smoothmuscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway[J]. Cell Signal, 2013, 25(1): 332-340.
7Shen RR, Zhou AY, Kim E, et al. TRAF2 is an NF-rdJ-activating oncogene in epithelial cancers[J]. Oncogene, 2015, 34(2): 209- 216.
8Jeong IK, Oh da H, Park S J, et al. Inhibition of NF-r,B prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells[J]. Exp Mol Med, 2011, 43(12): 684-692.
